We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKL icon
401
Markel Group
MKL
$24.6B
$20M 0.03%
10,438
+293
+3% +$595K
INSM icon
402
Insmed
INSM
$23.5B
$20M 0.03%
122,074
+12,673
+12% +$1.95M
DRI icon
403
Darden Restaurants
DRI
$22.1B
$19.8M 0.03%
100,886
+2,620
+3% +$539K
PAAS icon
404
Pan American Silver
PAAS
$18.7B
$19.7M 0.03%
360,916
+10,394
+3% +$599K
ON icon
405
ON Semiconductor
ON
$35.4B
$19.3M 0.03%
311,182
+8,619
+3% +$541K
LH icon
406
Labcorp
LH
$22.9B
$19.2M 0.03%
72,067
+1,916
+3% +$519K
LOGI icon
407
Logitech
LOGI
$14.8B
$19.2M 0.03%
212,644
+10,312
+5% +$950K
VRSN icon
408
VeriSign
VRSN
$24.2B
$19.1M 0.03%
77,100
+4,337
+6% +$1.03M
DGX icon
409
Quest Diagnostics
DGX
$22.9B
$19.1M 0.03%
97,284
+2,427
+3% +$472K
STE icon
410
Steris
STE
$20.6B
$19M 0.03%
86,005
+2,515
+3% +$615K
IMO icon
411
Imperial Oil
IMO
$60.1B
$19M 0.03%
145,437
+3,737
+3% +$419K
QSR icon
412
Restaurant Brands International
QSR
$25.6B
$18.9M 0.03%
256,702
+8,048
+3% +$565K
LYB icon
413
LyondellBasell Industries
LYB
$19.8B
$18M 0.03%
222,988
+5,758
+3% +$342K
HUM icon
414
Humana
HUM
$48.5B
$18M 0.03%
103,557
+2,765
+3% +$567K
FSLR icon
415
First Solar
FSLR
$22.1B
$18M 0.03%
91,006
+3,999
+5% +$884K
SBAC icon
416
SBA Communications
SBAC
$18.8B
$17.9M 0.03%
103,874
+2,992
+3% +$561K
CF icon
417
CF Industries
CF
$18.9B
$17.8M 0.03%
137,386
-3,183
-2% -$325K
BIIB icon
418
Biogen
BIIB
$30B
$17.8M 0.03%
96,864
-28,034
-22% -$5.17M
TSN icon
419
Tyson Foods
TSN
$20.1B
$17.7M 0.03%
276,698
+48,282
+21% +$3M
TROW icon
420
T. Rowe Price
TROW
$25.2B
$17.7M 0.03%
196,370
+2,042
+1% +$198K
ARES icon
421
Ares Management
ARES
$27.2B
$17.7M 0.03%
162,059
+4,286
+3% +$569K
BAP icon
422
Credicorp
BAP
$31.1B
$17.7M 0.03%
52,106
+534
+1% +$179K
BURL icon
423
Burlington
BURL
$22.3B
$17.6M 0.03%
54,039
+1,404
+3% +$430K
EQR icon
424
Equity Residential
EQR
$25.6B
$17.6M 0.03%
296,870
+9,611
+3% +$593K
MDB icon
425
MongoDB
MDB
$24.7B
$17.5M 0.03%
71,596
+7,021
+11% +$2.35M

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.